CIK 0001551306
- Large accelerated filer
Progyny, Inc.
Sign in to watch- Ticker
- PGNY
- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272220139
- Phone
- +1 212-888-3124
- Business address
- 1359 BROADWAY, 2ND FLOOR, NEW YORK, NY, 10018
- Former names
- Auxogyn, Inc., Auxogyn Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $22,674,844
- in 10 filings, $22.0M under 10b5-1 plans
Net −$22,674,844. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-10-24 | Dean Lloyd H Director | Grant or award · Stock Option (Right to Buy) | +584 | 584 | ||
| 2022-10-24 | Cohen Fred E Director | Grant or award | +3,480 | 12,132 | ||
| 2022-10-24 | Cohen Fred E Director | Grant or award · Stock Option (Right to Buy) | +15,660 | 15,660 | ||
| 2022-10-24 | Cohen Fred E Director | Grant or award · Stock Option (Right to Buy) | +1,460 | 1,460 | ||
| 2022-10-24 | HOLSTEIN ROGER C Director | Grant or award | +2,900 | 5,110 | ||
| 2022-10-24 | HOLSTEIN ROGER C Director | Grant or award · Stock Option (Right to Buy) | +14,500 | 14,500 | ||
| 2022-10-24 | Scott Cheryl Director | Grant or award | +2,900 | 8,110 | ||
| 2022-10-24 | Scott Cheryl Director | Grant or award · Stock Option (Right to Buy) | +14,500 | 14,500 | ||
| 2022-10-24 | GORDON KEVIN K Director | Grant or award | +2,900 | 10,110 | ||
| 2022-10-24 | GORDON KEVIN K Director | Grant or award · Stock Option (Right to Buy) | +14,500 | 14,500 | ||
| 2022-10-24 | Park Jeffrey G Director | Grant or award | +3,480 | 12,132 | ||
| 2022-10-24 | Park Jeffrey G Director | Grant or award · Stock Option (Right to Buy) | +16,240 | 16,240 | ||
| 2022-10-24 | Park Jeffrey G Director | Grant or award · Stock Option (Right to Buy) | +1,752 | 1,752 | ||
| 2022-10-20 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion | +2,248 | $3.95 | $9K | 252,693 |
| 2022-10-20 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −2,248 | $39.38 | $89K | 250,445 |
| 2022-10-20 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −562 | $39.38 | $22K | 185,575 |
| 2022-10-20 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion · Option (Right to Buy) | −2,248 | 1,471,465 | ||
| 2022-10-20 | Schlanger David J Executive Chairman | Exercise or conversion | +2,200 | $0.91 | $2K | 84,748 |
| 2022-10-20 | Schlanger David J Executive Chairman | Sale | −2,200 | $39.37 | $87K | 82,548 |
| 2022-10-20 | Schlanger David J Executive Chairman | Exercise or conversion · Option (Right to Buy) | −2,200 | 1,384,669 |
Page 39 of 77 · 1,524 trades